Early abstinence in cocaine pharmacotherapy trials predicts successful treatment outcomes

Journal of Substance Abuse Treatment

Volumn 37, Issue 3, 2009, Pages 313-317

  Plebani, Jennifer G ^a   Kampman, Kyle M ^a   Lynch, Kevin G ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Abstinence; Cocaine; Pharmacotherapy

Indexed keywords

AMANTADINE; BENZOYLECGONINE; DISULFIRAM; NALTREXONE; PROPRANOLOL;

ABSTINENCE; ARTICLE; CLINICAL TRIAL; COCAINE DEPENDENCE; HUMAN; PREDICTION; PRIORITY JOURNAL; TREATMENT OUTCOME; URINALYSIS;

COCAINE-RELATED DISORDERS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; SMOKING CESSATION; TIME FACTORS; TREATMENT OUTCOME;

EID: 69349100504     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2009.02.001     Document Type: Article

References (18)

1. Alterman A.I., Kampman K., Boardman C.R., Cacciola J.S., Rutherford M.J., McKay J.R., et al. A cocaine-positive baseline urine predicts outpatient treatment attrition and failure to attain initial abstinence. Drug and Alcohol Dependence 46 (1997) 79-85
2. Alterman A.I., McKay J.R., Mulvaney F.D., and McLellan A.T. Prediction of attrition from day hospital treatment in lower socioeconomic cocaine-dependent men. Drug and Alcohol Dependence 40 (1996) 227-233
3. Bisaga A., Aharonovich E., Garawi F., Levin F.R., Rubin E., Raby W.N., et al. Utility of lead-in period in cocaine dependence pharmacotherapy trials. Drug and Alcohol Dependence 77 (2005) 7-11
4. Bisaga A., Aharonovich E., Garawi F., Levin F.R., Rubin E., Raby W.N., et al. A randomized placebo-controlled trial of gabapentin for cocaine dependence. Drug and Alcohol Dependence 81 (2006) 267-274
5. Doherty K., Kinnunen T., Militello F.S., and Garvey A.J. Urges to smoke during the first month of abstinence: Relationship to relapse and predictors. Psychopharmacology 119 (1995) 171-178
6. Fagerstrom K.O., and Schneider N.G. Measuring nicotine dependence: A review of the Fagerstrom Tolerance Questionnaire. Journal of Behavioral Medicine 12 (1989) 159-182
7. Garvey A.J., Bliss R.E., Hitchcock J.L., Heinold J.W., and Rosner B. Predictors of smoking relapse among self-quitters: A report from the Normative Aging Study. Addictive Behaviors. 17 (1992) 367-377
8. Gourlay S.G., Forbes A., Marriner T., Pethica D., and McNeil J.J. Prospective study of factors predicting outcome of transdermal nicotine treatment in smoking cessation. British Medical Journal 309 (1994) 842-846
9. Heil S.H., Alessi S.M., Lussier J.P., Badger G.J., and Higgins S.T. An experimental test of the influence of prior cigarette smoking abstinence on future abstinence. Nicotine & Tobacco Research 6 (2004) 471-479
10. Higgins S.T., Badger G.J., and Budney A.J. Initial abstinence and success in achieving longer-term cocaine abstinence. Experimental and Clinical Psychopharmacology 8 (2000) 377-386
11. Higgins S.T., Heil S.H., and Plebani Lussier J. Clinical implications of reinforcement as a determinant of substance use disorders. Annual Review of Psychology 55 (2004) 431-461
12. Kampman K.M., Dackis C., Lynch K.G., Pettinati H.M., Tirado C., Gariti P., et al. A double-blind, placebo-controlled trial of amantadine and propranolol for the treatment of cocaine dependent patients with severe cocaine withdrawal symptoms. Drug and Alcohol Dependence 85 (2006) 129-137
13. Kampman K.M., Volpicelli J.R., Mulvaney F., Rukstalis M., Alterman A.I., Pettinati H., et al. Cocaine withdrawal severity and urine toxicology results from treatment entry predict outcome in medication trials for cocaine dependence. Addictive Behaviors 27 (2002) 251-260
14. Kenford S.L., Fiore M.C., Jorenby D.E., Smith S.S., Wetter D., and Baker T.B. Predicting smoking cessation: Who will quit with and without the nicotine patch. JAMA 271 (1994) 589-593
15. Levin F.R., Bisaga A., Raby W., Aharonovich E., Rubin E., Mariani J., et al. Effects of major depressive disorder and attention-deficit/hyperactivity disorder on the outcome of treatment for cocaine dependence. Journal of Substance Abuse Treatment 34 (2008) 80-89
16. Murphy S.A. An experimental design for the development of adaptive treatment strategies. Statistics in Medicine 24 (2005) 1455-1481
17. Pettinati H.M., Kampman K.M., Lynch K.G., Xie H., Dackis C., Rabinowitz A.R., et al. A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence. Addictive Behaviors 33 (2008) 651-667
18. Yudkin P.L., Jones L., Lancaster T., and Fowler G.H. Which smokers are helped to give up smoking using transdermal nicotine patches? Results from a randomized, double-blind, placebo-controlled trial. British Journal of General Practice 46 (1996) 145-148